Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology.
about
Diarrheagenic Escherichia coliComparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coliThe risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infectionsPathogenesis of thrombotic microangiopathiesShiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndromeSaliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.Colonic necrosis and perforation secondary to Escherichia coli O157:H7 gastroenteritis in an adult patient without hemolytic uremic syndrome.Haemolytic-uraemic syndrome in a dog.Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp.Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome.Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children.Hemolytic uremic syndrome incidence in New York.Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndromeSystematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?Rapid culture-free identification and molecular typing of Shiga toxin-producing Escherichia coli by PCR-RFLP.Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003.Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK.Shigella sonnei and hemolytic uremic syndrome: A case report and literature review.The detection of Vero cytotoxin-producing Escherichia coli and Shigella dysenteriae type 1 in faecal specimens using polymerase chain reaction gene amplification.Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjectsHemolytic uremic syndrome in dogs.A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigatorsIdentification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in FranceThe role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.Epidemiology of infection due to Escherichia coli O157: a 3-year prospective study.Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.A cluster of Escherichia coli O157:H7 infections with the hemolytic-uremic syndrome and death in California. A mandate for improved surveillance.Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct cultureConstruction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli.Analysis of Escherichia coli O157 clinical isolates by multilocus sequence typing.Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures.
P2860
Q24533466-DC6D27DE-3591-44D0-9490-FCD46EE06CB0Q24551733-731B52CF-E306-4A73-A736-72316F40C9FEQ24623245-1E744BF0-A1A6-4D37-A500-2C1CC1A60C0EQ24658043-2B864F80-400D-4CAC-90F0-102695B9E46CQ33302118-4B1172E9-9BE5-4787-B66F-8B1183BB09F7Q33337121-809977C7-EE44-4B56-85E8-684417950436Q33342197-1A7705DB-422F-47FC-ABB6-424C7FC95E65Q33343456-941CD178-7E73-4C79-9A84-072380118E8EQ33344755-C97788B0-5BA9-4F3B-BD2B-B8BD59ED5278Q33345764-7D3333D1-C618-40CD-9B5F-F3F0674D4113Q33358383-D90FD9B9-DF1F-4BBB-8549-DD1C805D0241Q33359241-A263D186-7FBC-4EE1-A999-C88E93592D5EQ33359877-63CF8B57-9C65-4CFE-B3E4-6E30939EC83FQ33361312-FF6A5F47-E91F-4E52-B913-6A7EFD5CE3D0Q33365846-884B6F97-056A-4B72-AC98-754C0DCCC4E2Q33369261-8853C925-1AAA-4351-844F-C9C33B22574BQ33372310-1F245FEA-A787-42F3-A220-610D7274D3B8Q33380075-110AD3EE-3D92-4ADB-99FC-90672584D179Q33386652-9C72709B-A93A-46B4-8B18-7AF48BDD1753Q33396329-84C359F5-57B4-4875-AAE0-757F79E6703EQ33400310-884199E5-190F-4A4D-943C-766CF7577EBBQ33402784-0CC3A605-763F-4179-A886-374FE551429EQ33412829-FD13778A-D4AF-475A-8607-135942B338E6Q33419153-A780FEA2-4D3F-46EE-8576-B2AE921FD724Q33421382-B3A7647F-DDFB-42A0-8342-9CB8CFCCD219Q33439653-5B48644F-5DA2-432C-B2D0-08571829CDA8Q33489775-CCD8FFBD-F5BD-4370-879E-580397E18480Q33491823-92C00DDC-BDF3-49BF-AC3C-85B1E47394ADQ33493161-00CAB591-284C-49A2-BA19-2E1D33A4E16EQ33494314-D1F57176-662F-4711-A1C1-55435AF3B3A4Q33494317-730CEE62-AD7D-408C-882C-DF2404175D52Q33494321-560852BB-700C-43F5-9AF2-FAC38566C3AFQ33494653-D779BFBE-7FE6-467E-9CB9-8F46F3788FECQ33495990-CD47F064-5592-4954-B053-B034205BB05EQ33497037-96407B7B-FC45-448B-83C9-5F8852BD3C89Q33497189-62F1746B-13D7-47FF-AC0A-8892F0A060E0Q33497617-0581ECDF-FF98-4CC2-BC43-A52AC29C79C2Q33754052-0B236687-8BC3-4173-A443-E1719F402216Q33777424-759E5155-CE8C-48FA-9BF0-8CD1D317C787Q33969693-C130075E-4DD2-45E0-A8DC-A10297FDC272
P2860
Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology.
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Escherichia coli O157:H7 and t ...... in establishing the etiology.
@ast
Escherichia coli O157:H7 and t ...... in establishing the etiology.
@en
type
label
Escherichia coli O157:H7 and t ...... in establishing the etiology.
@ast
Escherichia coli O157:H7 and t ...... in establishing the etiology.
@en
prefLabel
Escherichia coli O157:H7 and t ...... in establishing the etiology.
@ast
Escherichia coli O157:H7 and t ...... in establishing the etiology.
@en
P2093
P356
P1476
Escherichia coli O157:H7 and t ...... in establishing the etiology.
@en
P2093
P304
P356
10.1093/INFDIS/162.2.553
P407
P577
1990-08-01T00:00:00Z